Rule 425 Communication · 425
Standard BioTools Inc.
LABNASDAQEQUITYCurrent
Rule 425 Communication
Company context
Standard BioTools Inc. (NASDAQ: LAB) is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn and YouTube™.
Current securities
Historical securities (1)
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders · Regulation FD DisclosureNov 19, 2026
- 425 filingNov 16, 2026
- Other EventsNov 16, 2026
- SCHEDULE 13G/A - filed by MAK Capital Fund LP regarding STANDARD BIOTOOLS INC.Nov 16, 2026
- 10-Q filingNov 3, 2026
As-filed source
As filedOpen full document ↗